- Jun 30, 2020
Readily Available MRI Technique Could Shed Light on Common Pediatric Cancer
T1 mapping has the potential to determine neuroblastoma aggressiveness, as well as early efficacy of treatment. Read more: https://www.diagnosticimaging.com/view/readily-available-mri-technique-could-shed-light-on-common-pediatric-cancer
- Jun 26, 2020
Drug used in breast and ovarian cancer could lead to safer, more effective treatment for neuroblasto
A type of drug known as a PARP inhibitor, already used to treat breast and ovarian cancer, may be useful in treating children with high-risk neuroblastoma—a common childhood tumor with a low survival rate. Read more: https://medicalxpress.com/news/2020-06-drug-breast-ovarian-cancer-safer.html
- Jun 23, 2020
Online tool helps doctors predict whether childhood cancer treatment will lead to premature menopaus
Risk calculator developed by U of A master’s student could help reduce long-term health consequences for girls who survive cancer. Read more: https://www.folio.ca/online-tool-helps-doctors-predict-whether-childhood-cancer-treatment-will-lead-to-premature-menopause/
- Jun 23, 2020
Targeting stem cells: The path to curing poor-prognosis leukaemia
Researchers at Children's Cancer Institute have discovered what could prove a new and improved way to treat the poor-prognosis blood cancer, acute myeloid leukaemia or AML. Read more: https://www.eurekalert.org/pub_releases/2020-06/ccia-tsc061820.php
- Jun 8, 2020
Identifying survivors at high risk of secondary cancers
Scientists at St. Jude Children's Research Hospital are studying the combined effect of cancer treatments and inherited mutations in DNA-repair genes. Their results may help predict which survivors are at increased risk of another cancer. Read more: https://medicalxpress.com/news/2020-06-survivors-high-secondary-cancers.html
- Jun 8, 2020
A new immunotherapeutic agent for children and adolescents with advanced lymphoma
It establishes a new standard treatment with an improved cure rate for children with advanced non-Hodgkin lymphoma, mainly Burkitt lymphoma. Read more: https://www.eurekalert.org/pub_releases/2020-06/cccg-ani060320.php
- Jun 3, 2020
Cancer’s toll on the heart decades down the road
New research explores how to lower the risk of heart disease in childhood cancer survivors. Read more: https://www.fredhutch.org/en/news/center-news/2020/05/childhood-cancer-survivors-heart-health.html
- Jun 3, 2020
Children with Down syndrome, ALL at higher risk for poor outcomes
Children with Down syndrome and acute lymphoblastic leukemia continue to experience poorer outcomes than children with ALL who do not have Down syndrome, according to study results presented during the ASCO20 Virtual Scientific Program. Read more: https://www.healio.com/news/hematology-oncology/20200531/children-with-down-syndrome-all-at-higher-risk-for-poor-outcomes
- Jun 3, 2020
Childhood Cancer Survivors See Uptick in Colorectal Polyps
Childhood cancer survivors are developing colorectal polyps unrelated to a familial syndrome, the usual association, according to new findings from Dana-Farber Cancer Institute in Boston. Read more: https://www.curetoday.com/publications/heal/2020/spring-2020/childhood-cancer-survivors-see-uptick-in-colorectal-polyps
- Jun 1, 2020
Study Opens Up Possibility for Use of Precision Medicine in Pediatric Cancer
Matching children diagnosed with advanced cancers to targeted anti-cancer agents appears to show some potential for improving progression-free survival. Read more: https://www.medpagetoday.com/meetingcoverage/asco/86732